Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > "We are confident that our.......
View:
Post by ISAloser247 on Mar 28, 2012 3:37pm

"We are confident that our.......

..AS CONFIDENT AS 10 years ago ,-- "This alliance with Roche provides our company with expertise and resources essential to the advancement of ISA(TX)27 into the commercial marketplace." "The achievement of this shared objective will generate the maximum benefit for our companies, our shareholders and the millions of people around the world living with organ transplants and auto-immune diseases."

Arbitrations are never clean-cut,  they are ALWAYS MESSY.  10 years of failures, with millions in salary compensation wasted,  there is NOTHING, NOTHING TO BE PROUD OF!!!!  ACTIONS, SPEAK LOUDER

THAN WEASEL WORDS ---ABOUT THE FUTURE--ABOUT UNRESOLVED ISSUES!!! THE PAST IS ALWAYS DREDGED UP!!!

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities